Recently, Next-Generation Sequencing detected highly recurrent somatic mutations including GTPase RHOA and epigenetic regulators, which pinpointing novel candidates for the investigation of targeted therapies in AITL. Here, RHOA is linked to angioimmunoblastic T-cell lymphoma.